SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST (1490)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-glomerular basement membrane (GBM) antibodies (K011348 | K011348) HIGH
Effective Date: 2001-06-22

Other General Immunology Devices:

Medical DeviceComplexity
CIRRUS DIAGNOSTICS IMMULITEView Complexity
Sebia CAPILLARYS 2View Complexity
Sigma Diagnostics SIA CMV IgGView Complexity
Arlington Scientific Inc., ASI CMV IgMView Complexity
Roche Diagnostics Cobas MiraView Complexity
MarDx Parietal Cell Antibody Test SystemView Complexity
Phadia 250View Complexity
Diagnostic Products Corporation IMMULITE 2000 AnalyzerView Complexity
Bio-Flash Instrumentation SystemView Complexity
HELIX DIAGNOSTICS ANTI-CENTROMERE EIAView Complexity